Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03819478 · ClinicalTrials.gov registry record · NA
Utilizing Protein During Weight Loss to Impact Physical Function and Bone
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 187
- Enrollment target
NCT03819478: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT03819478 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 187 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03819478, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 187 participants
- Enrollment target
Study Summary
This study is an ancillary study to the Utilizing Protein During Weight Loss to Impact Physical Function (UPLIFT) trial (NCT03074643) to evaluate the effects of diet composition (i.e., amount of protein and carbohydrate) during a 6-month weight loss intervention and 12-months of follow-up on bone phenotypes in obese older adults. Participants will receive either a protein or carbohydrate supplement along with a behavioral weight loss intervention.
Primary Outcome
To determine the effects of a higher protein / lower CHO diet vs. lower protein / higher CHO diet on the 18-month change from baseline in total hip trabecular volumetric bone mineral density (vBMD). Total hip trabecular vBMD (in mg/cm\^3) was measured from the baseline and 18-month quantitative CT scans using the Mindways Model 3 phantom to calibrate the vBMD measures. The 18-month change in total hip trabecular vBMD from baseline is reported for this outcome measure.
Interventions
- BEHAVIORAL Weight loss intervention months 0-6
- BEHAVIORAL Exercise intervention months 0-6
- DIETARY_SUPPLEMENT NutraBio™ CarboMax Supplement
- DIETARY_SUPPLEMENT 6-month NutraBio™ 100% Whey Protein Isolate Supplement
- DIETARY_SUPPLEMENT 18-month NutraBio™ 100% Whey Protein Isolate Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2017-05-03 |
| Est. Completion | 2022-04-28 |
| Phase | NA |
What the finished NCT03819478 record still lists
NCT03819478 is an interventional study that assigns participants to a tested intervention. The registered 187 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 5 interventions - of which Weight loss intervention months 0-6 is the first listed.
NCT03819478 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03819478 about?
NCT03819478 is a clinical study titled "Utilizing Protein During Weight Loss to Impact Physical Function and Bone". This study is an ancillary study to the Utilizing Protein During Weight Loss to Impact Physical Function (UPLIFT) trial (NCT03074643) to evaluate the effects of diet composition (i.e., amount of protein and carbohydrate) during a 6-month weight loss intervention and 12-months of follow-up on bone ph...
What is the current status of trial NCT03819478?
This trial is currently completed. It is a NA study. The enrollment target is 187 participants. The study started on 2017-05-03. Estimated completion is 2022-04-28.
What interventions are being tested in trial NCT03819478?
The interventions under investigation include: Weight loss intervention months 0-6 (BEHAVIORAL), Exercise intervention months 0-6 (BEHAVIORAL), NutraBio™ CarboMax Supplement (DIETARY_SUPPLEMENT), 6-month NutraBio™ 100% Whey Protein Isolate Supplement (DIETARY_SUPPLEMENT), 18-month NutraBio™ 100% Whey Protein Isolate Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03819478?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03819478's enrollment target sits among peer trials
187 579th of 2000 higher than 1,422 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06153251 · 187 participants · Phase 1
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
- NCT06254898 · 187 participants · NA
Use of Incentives for Stressful Medical Procedures
- NCT07062237 · 187 participants · NA
A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence
- NCT07217574 · 187 participants
Program in Oncology for Tribal Health Systems.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI